The pharmaceutical landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike shots, this approach offers a simpler way to provide GLP-1 medications. These devices steadily release the medication through the skin offering a stable dose of the therapeutic agent, which can enhance glucose r